InvestorsHub Logo
icon url

bfost

10/31/17 12:55 PM

#550 RE: DewDiligence #549

yup UPOD - beat and raise.
icon url

maxxam

11/04/17 9:11 AM

#551 RE: DewDiligence #549

Hey Dew (Biko), can you please share about any other interesting bio companies with potential in the next 10 years? I know you from the GG forum.
icon url

TREND1

11/21/17 11:37 AM

#568 RE: DewDiligence #549

*****Very good article IMHO.

11/21 Exact Sciences, We Bid You Farewell


•EXAS share price more than quadrupled since the beginning of 2017. Time to take profit.

•EXAS has generated losses since its inception and expects to continue to incur losses in the near future.

•EXAS is currently valued at more than 27 times price-to-2017-sales, rather pricey for the molecular diagnostics industry sector.



https://seekingalpha.com/article/4126796-sold-cologuard-maker-exact-sciences?auth_param=1vat:1d18h27:bb41b36a79b3544547eed9f8b9a0cbb6&uprof=51#alt2